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Small RNAs (sRNAs) associate with Argonaute (AGO) proteins in
effector complexes, termed RNA-induced silencing complexes (RISCs),
which regulate complementary transcripts by translation inhibition
and/or RNA degradation. In the unicellular alga Chlamydomonas,
several metazoans, and land plants, emerging evidence indicates
that polyribosome-associated transcripts can be translationally re-
pressed by RISCs without substantial messenger RNA (mRNA) desta-
bilization. However, the mechanism of translation inhibition in a
polyribosomal context is not understood. Here we show that Chla-
mydomonas VIG1, an ortholog of the Drosophila melanogaster Vasa
intronic gene (VIG), is required for this process. VIG1 localizes pre-
dominantly in the cytosol and comigrates with monoribosomes and
polyribosomes by sucrose density gradient sedimentation. A VIG1-
deleted mutant shows hypersensitivity to the translation elonga-
tion inhibitor cycloheximide, suggesting that VIG1 may have a
nonessential role in ribosome function/structure. Additionally,
FLAG-tagged VIG1 copurifies with AGO3 and Dicer-like 3 (DCL3),
consistent with it also being a component of the RISC. Indeed,
VIG1 is necessary for the repression of sRNA-targeted tran-
scripts at the translational level but is dispensable for cleavage-
mediated RNA interference and for the association of the
AGO3 effector with polyribosomes or target transcripts. Our re-
sults suggest that VIG1 is an ancillary ribosomal component and
plays a role in sRNA-mediated translation repression of polyribosomal
transcripts.
microRNA | RNA interference | SERBP1 | RNA silencing | VIG1
Several classes of small RNAs (sRNAs) have been recognizedin diverse eukaryotes and play essential roles in a broad array
of biological processes (1–5). MicroRNAs (miRNAs) are generally
processed, by RNase III enzymes such as Dicer, from imperfectly
paired stem-loop regions of single-stranded endogenous RNAs,
whereas small interfering RNAs (siRNAs) are produced from long,
near-perfectly complementary double-stranded RNAs (dsRNAs)
of various origins (1–5). These sRNAs are incorporated into ef-
fector complexes, known as (micro)RNA-induced silencing com-
plexes ([mi]RISCs), which contain Argonaute (AGO) proteins as
core components (1–5). AGOs bind sRNAs and use them as guides
to identify complementary sequences in nucleic acids targeted for
silencing. Highly complementary sRNA–mRNA hybrids often
trigger AGO-mediated endonucleolytic cleavage of transcripts,
the best-characterized mechanism of posttranscriptional gene si-
lencing mediated by siRNAs and, in land plants, by many miRNAs
(1, 2, 4). Conversely, imperfect sRNA–mRNA hybrids, with cen-
tral bulges or mismatches, frequently lead to translation inhibition
and/or exonucleolytic (AGO “slicer”-independent) transcript decay
(1, 3–5). However, recent evidence indicates that sRNAs perfectly
complementary to a target mRNA can also cause translation re-
pression (2, 4, 6). This outcome may result from the association of
sRNAs with AGOs that lack endonucleolytic activity or from mod-
ulation of the AGO endonucleolytic activity by posttranslational
modifications and/or by interaction with ancillary factors in an
(mi)RISC (3, 4, 6).
Substantial progress has been made in our understanding of the
mechanisms of miRNA-mediated posttranscriptional gene silenc-
ing. In metazoans, AGO-miRNA binding to the 3′ untranslated
region (UTR) of a target transcript recruits a glycine-tryptophan
repeat-containing protein (GW182 or TNRC6). GW-repeat pro-
teins interact with the cytoplasmic poly(A)-binding protein, asso-
ciated with the mRNA poly(A) tail, and with the CCR4–NOT and
PAN2–PAN3 deadenylase complexes (1, 3–5). CCR4–NOT, in
turn, recruits the RNA helicase DDX6, which is thought to play an
important role in translation repression (1, 3–5). The coordinated
action of these proteins results in inhibition of cap-dependent
translation, at an initiation step, and transcript deadenylation,
eventually causing mRNA degradation through decapping and
5′-to-3′ exonucleolytic decay (1, 3–5). Genome-wide proteomic
and transcriptomic analyses, after the removal or the ectopic expression
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of miRNAs, suggest that this slicer-independent degradation of
target transcripts may account for most of the miRNA-mediated
stable repression in many postembryonic cells (1, 4, 5).
In contrast, in embryonic stem cells and during early embryo-
genesis of metazoans, miRISC binding to target messenger RNAs
(mRNAs) mainly causes translation inhibition, with little effect on
transcript stability (1, 7, 8). Similar observations have been reported
in neurons, where reversible miRISC-mediated silencing reg-
ulates synaptic plasticity (9). Intriguingly, GW-repeat proteins are
absent from the miRISC in the Caenorhabditis elegans germline (7)
and from the polyribosome-associated miRISC that strongly in-
hibits translation upon serum starvation inDrosophila melanogaster
S2 cells (10). Moreover, in somatic mammalian cell lines, certain
miRNAs binding to the protein-coding sequence (CDS) of tran-
scripts repress translation, through a GW182/TNRC6-independent
mechanism, without triggering mRNA destabilization (11). Thus,
in metazoans, miRNAs appear to regulate target transcripts via
several mechanisms that can be modulated by cellular context,
miRISC composition, and subcellular localization, as well as target
mRNA-specific effects (4, 12, 13).
In land plants, even the slicer mode of miRNA action appears
to target (many) translating mRNAs. By isolating poly(A) RNAs
having a 5′ monophosphate (as a result of RNA cleavage/deg-
radation) and identifying the nucleotide positions of the 5′ ends,
a 3-nt periodicity in the RNA degradation products within the
CDS was observed for a number of miRNA targets, suggesting
that 5′-to-3′ degradation accompanies the codon-by-codon trans-
location of elongating ribosomes (2, 14). This is consistent with
findings that AGO1 and miRNAs associate with polyribosomes in
Arabidopsis thaliana (2, 4). In this species, several miRNAs with a
high degree of sequence complementarity to target transcripts can
trigger both mRNA cleavage and translation repression (2, 4, 15).
Plants and green algae lack orthologs of the metazoan GW182/
TNRC6 proteins and, in A. thaliana, the known factors required
for miRNA-mediated translation inhibition include the microtubule-
severing enzyme KATANIN1, decapping enhancer VARICOSE,
GW-containing protein SUO, endoplasmic reticulum (ER) mem-
brane protein ALTERED MERISTEM PROGRAM1, and
dsRNA-binding protein DRB2 (2, 4, 15, 16). Subcellular localiza-
tion and fractionation studies indicated that miRNA-mediated
translation repression mainly occurs on membrane-bound polyri-
bosomes, likely associated with the ER (2, 4, 15). Studies with ly-
sates from tobacco BY-2 cells suggested that the plant (mi)RISC,
bound to the 5′ UTR or the CDS of a transcript, can sterically
block the recruitment or the movement of ribosomes (17). How-
ever, a preferential accumulation of ribosome footprints was not
observed in the region upstream of CDS miRNA target sites in A.
thaliana Ribo-seq (sequencing) or RNA degradome data (14, 18).
Translation inhibition mediated by sRNAs also occurs in C.
reinhardtii (6, 19, 20) and the translationally repressed transcripts
remain associated with polyribosomes (6). Global ribosome pro-
filing in parallel with RNA-seq and quantitative proteomics on a
Dicer mutant and its Dicer-complemented strain revealed that
Chlamydomonas miRNAs regulate endogenous targets mainly by
pairing to the CDS of transcripts, leading to RNA degradation
and/or translation repression (20). However, ribosome footprints
were not piled up upstream of the miRNA-binding sites (20).
Thus, sRNA-mediated translation repression of polyribosome-
associated transcripts is a widespread phenomenon in eukaryotes
but the actual molecular mechanism(s) remains largely uncharac-
terized. Here, we show that a Chlamydomonas ortholog of the D.
melanogaster Vasa intronic gene (VIG) and mammalian SERPINE1
mRNA-binding protein 1 (SERBP1) is required for translation re-
pression mediated by siRNAs/miRNAs. Chlamydomonas VIG1 is a
component of the (mi)RISC, associates with translating ribosomes
in an mRNA-independent manner, and may possibly modulate
multiple steps of protein synthesis.
Results
VIG1 Is Required for Translation Repression Mediated by siRNAs/
miRNAs. In C. reinhardtii, the tryptophan synthase β-subunit (TSβ;
encoded by the MAA7 gene) is required to convert the indole
analog 5-fluoroindole (5-FI) into the toxic tryptophan analog 5-
fluorotryptophan. Suppression of MAA7 by RNA interference
(RNAi), triggered by dsRNAs produced from inverted-repeat
(IR) transgenes, results in strains resistant to 5-FI (6, 21). In
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Fig. 1. Chlamydomonas VIG1 is required for the siRNA-mediated translation repression of the MAA7 transcript. (A) Growth and survival of the indicated
strains on TAP medium with or without 7 μM 5-fluoroindole. CC-124, wild-type strain; Maa7-IR44, CC-124 transformed with an IR transgene designed to
induce RNAi of MAA7; vig1, VIG1 deletion mutant; vig1(tagVIG1)-3 and -6, transgenic strains of vig1 transformed with FLAG-CBP-VIG1 under the control of
the PsaD promoter. (B) Immunoblot analysis of tryptophan synthase β-subunit levels. Immunodetection of histone H3 was used as a control for equivalent
loading of the lanes. (C) Northern blot analysis ofMAA7 transcript levels. The same filter was reprobed with the coding sequence of ACT1 (encoding actin) as
a control for similar loading of the lanes. (D) Northern blot analysis of MAA7 siRNAs in the indicated strains. The same filter was reprobed with the U6 small
nuclear RNA sequence to assess the amount of sample loaded per lane. (E) Northern blot analyses of sRNAs isolated from the indicated strains and detected
with probes specific for Chlamydomonas miRNAs. (F) Immunoblot analysis of AGO3/2 proteins in the indicated strains. The asterisk indicates a nonspecific
cross-reacting antigen.
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several transgenic strains, like Maa7-IR44, MAA7 is silenced by
siRNA-mediated translation repression of polyribosome-associated
transcripts, without mRNA destabilization (6). In order to gain some
insights into this process, we generated a library of RNAi-defective
insertional mutants in the Maa7-IR44 background. One such mu-
tant, designated vig1, contained a deletion of the Cre09.g393358
(VIG1) gene, encoding the only Chlamydomonas member of a
conserved eukaryotic protein family that includes VIG and
SERBP1 (SI Appendix, Figs. S1A and S2). The entire VIG1 gene
is deleted in Chlamydomonas vig1 (SI Appendix, Fig. S3A) and no
VIG1 transcript is detected, by Northern blotting, in the mutant
background (SI Appendix, Fig. S3B).
The vig1 mutant showed sensitivity to 5-FI, indicating a defect
in the RNAi-mediated suppression of MAA7 (Fig. 1A). More-
over, it contained TSβ-protein amounts quite similar to those in
the wild-type CC-124 strain (Fig. 1B), without appreciable changes
in theMAA7 transcript abundance (Fig. 1C).MAA7 siRNA levels
were slightly reduced in the mutant background (Fig. 1D), as were
the amounts of a few miRNAs (Fig. 1E) and of AGO3/2 (Fig. 1F),
the main core components of the (mi)RISC in Chlamydomonas
(19). However, the barely noticeable reduction in components of
the RNAi machinery seemed insufficient to explain the defect in
siRNA-mediated translation repression ofMAA7. Transformation
of the vig1mutant with a transgene stably expressing FLAG-CBP–
tagged VIG1 (Materials and Methods) reverted all described
phenotypes (Fig. 1).
We also examined how the deletion of VIG1 affected the ex-
pression of Chlamydomonas genes regulated by endogenous
miRNAs/siRNAs. We already demonstrated that Cre16.g683650
(encoding a predicted protein kinase) is translationally repressed by
the miR_C sRNA (22). The miR_C binding site in theCre16.g683650
mRNA overlaps the stop codon and contains a mismatch with
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Fig. 2. Chlamydomonas vig1 mutant is defective in the translation repression, by an endogenous miRNA, of Cre16.g683650 (encoding a predicted protein
kinase of unknown function). (A) Ribosome profiling of the Cre16.g683650 transcript. The diagram (Top) depicts the hybridization of miR_C to its recognition
site, overlapping the stop codon, in the Cre16.g683650 mRNA. The mismatch to nucleotide 10 of the miRNA would prevent AGO-mediated cleavage of the
target transcript. Histograms of the 5′-end positions of ribosome-protected fragments (Ribo-seq; blue) or of normalized total RNA reads (RNA-seq; gray) are
shown along the length of the mRNA schematic (CDS is indicated by the orange box). Ribosome-protected fragments were predominantly 27 (or 28) nt in
length and their 5′ ends mapped to the second (or first) nucleotide position of codons, consistent with previous genome-wide Ribo-seq analyses in
Chlamydomonas (56). The distribution on the transcript of RNA-seq reads serves as a control for a possible technical bias in the detection of certain mRNA
sequences. The y axes of the histogram graphs indicate read frequency. (B) Immunoblot and semiquantitative RT-PCR analyses of Cre16.g683650 protein and
transcript levels in the indicated strains. Immunodetection of histone H3 was used as a control for equivalent loading of proteins in the lanes. Amplification of
ACT1 (encoding actin) transcripts is shown as an RT-PCR input control. CC-124, wild-type strain; Maa7-IR44, CC-124 transformed with an IR transgene designed
to induce RNAi of MAA7; vig1, VIG1 deletion mutant; vig1(tagVIG1)-3, transgenic strain of vig1 transformed with FLAG-CBP-VIG1 under the control of the
PsaD promoter.
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nucleotide 10 of the sRNA, which would hinder AGO-mediated
cleavage (Fig. 2A). As with MAA7, Cre16.g683650 was transla-
tionally derepressed in the vig1 mutant without any obvious al-
teration in its transcript level (Fig. 2B). In contrast, the regulation
of 2 mRNAs, corresponding to Cre17.g697550 and Cre12.g552950,
targeted for cleavage by Chlamydomonas miRNAs and/or en-
dogenous siRNAs (22, 23) was not defective in the mutant back-
ground. Their transcript abundance did not change in vig1 relative
to the wild-type or the complemented strains (SI Appendix, Fig.
S4A). In addition, the steady-state levels of several miRNAs, in-
cluding miR_C, and of the transcripts for the 3 AGOs encoded in
the Chlamydomonas genome were not substantially altered in the
vig1 mutant (SI Appendix, Fig. S4 B and C).
These results, taken together, suggest that Chlamydomonas
VIG1 is required for sRNA-mediated translation repression but
seems entirely dispensable for sRNA-mediated target RNA
cleavage/degradation. We have previously reported that sRNA-
repressed transcripts were found associated with polyribosomes
by sucrose density gradient centrifugation (6). Although ribosome-
profiling data on individual transcripts tend to be noisy without
very deep coverage, we nevertheless also examined, by Ribo-seq,
the association with ribosomes of the miR_C translationally re-
pressed Cre16.g683650 transcript. Ribosome-protected mRNA
fragments (RPFs) of typical length distribution and with the 3-nt
periodicity indicative of translationally active ribosomes were clearly
detected (Fig. 2A). Moreover, the RPFs were fairly uniformly
spread along the CDS, without any obvious ribosome stalling
upstream of the miR_C binding site (Fig. 2A).
VIG1 Copurifies with (mi)RISC Core Components. VIG/SERBP1 has
been previously identified as a component of the (mi)RISC in D.
melanogaster, C. elegans, and human cells (24, 25). However,
its role has remained somewhat enigmatic since its down-
regulation caused a slight (cleavage-mediated) RNAi defect in
D. melanogaster and no obvious RNAi deficiency in C. elegans
(24). To explore whether Chlamydomonas VIG1 might be an
(mi)RISC component, we affinity purified FLAG-CBP–tagged
VIG1 from RNase A-treated cell lysates of a complemented vig1
transgenic strain and identified associated proteins by mass spec-
trometry (Fig. 3A). As a negative control, we carried out similar
purifications from a transgenic strain expressing a FLAG-CBP–
tagged bleomycin resistance protein (Ble) from Streptoalloteichus
hindustanus. In 3 independent experiments, VIG1 copurified with
AGO3 and DCL3 (Fig. 3A and SI Appendix, Table S1), 2 well-
characterized core RNAi components in Chlamydomonas (19, 20,
22). In addition, VIG1 associated, in at least 2 experiments, with
putative mRNA splicing factors (SART1, squamous cell carci-
noma antigen recognized by T cells 1; SRP23, serine arginine rich-
like protein 23), several components of the protein translation
machinery (eIF3A, eukaryotic translation initiation factor 3 sub-
unit A; eIF3M, eukaryotic translation initiation factor 3 subunit
M; eIF4A, eukaryotic translation initiation factor 4 subunit A; eS4
[RPS4], 40S ribosomal protein S4e; eS7 [RPS7], 40S ribosomal
protein S7e; eL13 [RPL13], 60S ribosomal protein L13e; uL13
[RPL13A], 60S ribosomal protein L13A), a putative ATP-dependent
RNA helicase (HEL61), and protein arginine N-methyltransferase
2 (PRMT2) (Fig. 3A and SI Appendix, Table S1). The associa-
tions appear to be specific, since none of these proteins was
detected in 3 equivalent purifications with FLAG-CBP-Ble, and
RNA-independent, since the cell lysates were treated with
RNase A.
The (mi)RISC can catalyze the endonucleolytic cleavage of
RNA substrates, as directed by complementarity to its associated
siRNAs/miRNAs. Since FLAG-CBP-VIG1 and associated pro-
teins were purified from cells containing MAA7 siRNAs, which
we have previously characterized by sequencing (6, 21), we
designed a complementaryMAA7 RNA substrate to test whether
the isolated complex showed sequence-specific nuclease activity
in vitro. In this assay, expected cleavage products were observed
for the full reactions with or without ATP (Fig. 3B). However, the
endonucleolytic activity was abolished by the addition of EDTA,
which chelates the Mg2+ cofactors required for AGO slicer ac-
tivity. As controls, no specific cleavage was observed by incuba-
tion of the homologous RNA substrate with FLAG-CBP-Ble or
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Fig. 3. VIG1 is a bona fide (mi)RISC component. (A) FLAG-CBP-VIG1–associated proteins, isolated by affinity purification, were separated by SDS/PAGE and
visualized by Sypro Ruby staining. The indicated proteins were identified by mass spectrometry analyses. A mock purification with FLAG-CBP–tagged Ble
(conferring resistance to bleomycin) is also shown. The asterisk indicates the FLAG-CBP-VIG1 protein. (B) In vitro RISC cleavage assay. The diagram (Top)
depicts the homologous RNA substrate, hybridizing to 2 fully complementary MAA7 siRNAs, and the predicted cleavage sites generating 32P-labeled 5′-RNA
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by incubation of a nonhomologous RNA substrate with FLAG-
CBP-VIG1 (Fig. 3B). Thus, C. reinhardtii VIG1 appears to be an
(mi)RISC component, part of a complex with AGO3 that is ca-
pable of siRNA-directed sequence-specific RNA cleavage. It is
possible, but currently untested, that VIG1 may affect to some
degree (mi)RISC loading/stability, explaining the very minor re-
duction in AGO3/2 and certain siRNA/miRNA levels in the vig1
strain (Fig. 1 D–F). However, it is unlikely that VIG1 is required
for target RNA cleavage since, as already mentioned, its absence
in the vig1 mutant does not result in deficient regulation of endog-
enous sRNA targets subject to cleavage/degradation (SI Appendix,
Fig. S4A). Interestingly, in its normal cellular context, the RISC
represses the MAA7 transcript at the translational level without
mRNA cleavage/degradation (Fig. 1C). In contrast, the in vitro
purified RISC can cleave an MAA7 homologous RNA (Fig. 3B).
We speculate that some associated factor(s) and/or posttransla-
tional modification(s), which might suppress AGO3 endonucleo-
lytic activity in vivo, may have been lost during the purification.
VIG1 Is Mainly Located in the Cytosol and Associates with Bona Fide
Translating Ribosomes. VIG1 is predicted to be a structurally
disordered protein, with intrinsically disordered regions covering
∼83% of the polypeptide length (SI Appendix, Fig. S1B). Some of
these regions consist of arginine/glycine-rich (RG/RGG) repeats
(SI Appendix, Fig. S1A). However, 2 sequence domains are well-
conserved in putative VIG1 orthologs from a wide spectrum
of eukaryotes: the Stm1_N domain, found in the Saccharomyces
cerevisiae suppressor of Tom 1 (Stm1) protein (SI Appendix, Figs.
S1A and S5), and the HABP4/SERBP1 (PAI-RBP1) domain,
found in the HABP4 family of hyaluronan-binding proteins and
in SERBP1 (SI Appendix, Figs. S1A and S6). Cryo-EM struc-
tures of eukaryotic 80S ribosomes revealed that yeast Stm1,
D. melanogaster VIG2, and mammalian SERBP1 interact di-
rectly with inactive ribosomes (26, 27). Stm1 and SERBP1 have
been proposed to function as clamping factors that prevent ribo-
some subunit disassembly and preclude their degradation when
translation is massively slowed down under nutrient deprivation/
stress conditions (27–30).
To begin assessing the association of Chlamydomonas VIG1
with ribosomes, we examined its subcellular localization by im-
munofluorescence imaging. FLAG-CBP-VIG1 was found to lo-
calize mainly in the cytosol, with some preference for perinuclear
regions (Fig. 4 and SI Appendix, Fig. S7). The parental Maa7-IR44
strain was used as a negative control, to verify the absence of
background fluorescence in the Alexa Fluor 488 channel corre-
sponding to FLAG-CBP-VIG1. We also tested conditions that
might potentially alter VIG1 localization, by virtue of its associa-
tion with the (mi)RISC and/or with ribosomes. Heat stress triggers
translational arrest and the formation of stress granules, cyto-
plasmic aggregates of stalled translational preinitiation complexes
(which can include 40S ribosomal subunits and translation initia-
tion factors), after polyribosome disassembly (31). In contrast,
cycloheximide treatment “freezes” translating ribosomes on tran-
scripts (6, 32). However, the localization of FLAG-CBP-VIG1 did
not change appreciably under any of the conditions analyzed (Fig.
4 and SI Appendix, Fig. S7).
To examine the possible association of VIG1 with translating
ribosomes, we carried out polyribosome profiling by sucrose density
gradient sedimentation. A fraction of VIG1 comigrated with
monoribosomes and polyribosomes, suggesting that VIG1 does
associate with actively translating ribosomes (Fig. 5A). Interestingly,
a fraction of AGO3/2 also comigrated with polyribosomes (Fig. 5A),
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Fig. 4. Immunofluorescence localization of FLAG-CBP–tagged VIG1. Phase-contrast images of the cells, immunolocalization of epitope-tagged VIG1 (de-
tected with an antibody conjugated to Alexa Fluor 488), DAPI staining of nuclear and organellar DNA, and merged images. Representative images are shown,
with the location of the nucleus indicated by “N.” Cells were grown to middle logarithmic phase in TAP medium, collected by centrifugation, and then
processed for immunofluorescence microscopy. Aliquots of cells were also exposed to 42 °C for 45 min (heat shock) or incubated in the presence of 50 μg/mL
cycloheximide for 2 h prior to preparation for immunofluorescence microscopy. vig1(tagVIG1)-3, VIG1 deletion mutant expressing a transgene of FLAG-CBP-
VIG1 under the control of the PsaD promoter. Maa7-IR44, parental strain. (Scale bars, 5 μm.)
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supporting a connection of the (mi)RISC with translating ribosomes
and consistent with the previously reported association of sRNAs
with polyribosomes (6). To determine further whether the fast-
sedimenting VIG1 and AGO3/2 were indeed associated with
polyribosomes, we treated lysates with EDTA, known to chelate
Mg2+ and dissociate translating cytosolic ribosomes into their 40S
and 60S subunits (6). This caused, as expected, redistribution of all
tested proteins to the subpolyribosomal region of the gradient (SI
Appendix, Fig. S8A). Thus, VIG1 localizes predominantly in the
cytosol of C. reinhardtii and associates with monoribosomes and
polyribosomes.
VIG1 Appears to Be an Auxiliary Protein of Translating Ribosomes but
Is Not Required for AGO3 Interaction with Polyribosomes or Target
Transcripts. In wild-type C. reinhardtii, VIG1 is an abundant
protein, similar in relative levels to ribosomal proteins and at
least 15 times more abundant than AGO3 (SI Appendix, Fig.
S9A). This implies that the majority of cellular VIG1 is unlikely
to be part of the (mi)RISC. The affinity-purification experiments
indicated that VIG1 interacts (directly or indirectly but in an
RNA-independent manner) with several translation initiation
factors and ribosomal proteins (Fig. 3A). Additionally, the vig1
mutant is hypersensitive to exposure to cycloheximide, which
inhibits translation elongation (6), but shows lower sensitivity to
exposure to hygromycin B or rapamycin (SI Appendix, Fig. S9B).
Hygromycin B seems to affect decoding fidelity as well as trans-
location of mRNA and tRNAs on the ribosome (6), whereas
rapamycin is an inhibitor of the mTOR (mechanistic target of
rapamycin) kinase. Together with the described VIG1 comigration
with mono/polyribosomes on sucrose density gradients (Fig. 5A),
these observations suggested that this protein may have an ancillary
role(s) in ribosome function/structure (besides being a putative
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Fig. 5. VIG1 is not required for AGO3 association with polyribosomes or target transcripts. (A) Polyribosome profile of a vig1(tagVIG1)-3 lysate treated with
150 μg/mL cycloheximide and fractionated by sucrose density gradient centrifugation (Top). The distribution of the AGO3/2, RPL37, and FLAG-CBP-
VIG1 proteins in the gradient fractions was examined by immunoblotting (Bottom). The location of monoribosomes (M) and polyribosomes (Poly) in the
profile is shown above the blots. The asterisk indicates a nonspecific cross-reacting antigen. (B) Polyribosome profiles of the Maa7-IR44 and vig1 strains and
immunological detection of AGO3/2 and RPL37 distribution in the gradient fractions. (C) RNA-binding protein immunoprecipitation and subsequent RT-PCR
detection of AGO3-associated transcripts. RIP with anti–FLAG-M2 agarose beads (FLAG-IP) was performed from lysates of the indicated strains. Input RNA
corresponded to 5% of the total purified amount. ACT1 was examined as a control transcript, not targeted by an sRNA-mediated mechanism. Maa7-
IR44(FLAG-AGO3)-56, transgenic strain of Maa7-IR44 transformed with FLAG-tagged AGO3; vig1(FLAG-AGO3)-31, transgenic strain of vig1 transformed
with FLAG-tagged AGO3; Maa7-IR44(FLAG-Ble), transgenic strain of Maa7-IR44 transformed with FLAG-tagged Ble.
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[mi]RISC component). A nonessential role of VIG1 in ribosome
function is supported by the fact that overall protein abundance did
not change appreciably in the vig1 mutant relative to the wild-type
or the complemented strains (SI Appendix, Fig. S10). Moreover, un-
der standard laboratory conditions in TAP (Tris-acetate-phosphate)
medium, lack of VIG1 does not appear to affect cell growth (Fig.
1A and SI Appendix, Fig. S9B), suggesting that VIG1 may only
play a minor role (if any) in general protein synthesis.
To examine in more detail the function of VIG1 in sRNA-
mediated translation inhibition, we tested whether it was required
for association of AGO3/2 with polyribosomes or with translation-
ally repressed target RNAs. However, the distribution of AGO3/
2 by sucrose gradient sedimentation was very similar in both vig1
and its parental strain (Fig. 5B), suggesting that AGO3/2 interaction
with polyribosomes is VIG1-independent. Our anti-AGO3/2 anti-
body was raised against an AGO3 peptide (21) but, in immunoblots,
it also recognizes the much less abundant AGO2 homolog (19).
However, its binding affinity appears to be too low for the im-
munoprecipitation of the native AGO proteins. Thus, in order to
examine AGO3–target RNA interactions by RNA-binding pro-
tein immunoprecipitation (RIP), we generated transgenic strains
expressing FLAG-tagged AGO3 in the vig1 and the Maa7-IR44
backgrounds. We selected transgenic strains expressing FLAG-
AGO3 at similar levels and where the introduced tagged protein
replaced a fraction of the endogenous AGO3, rather than
overexpressing it to unphysiological levels [SI Appendix, Fig. S8B;
Maa7-IR44(FLAG-AGO3)-56 and vig1(FLAG-AGO3)-31]. As
in mammalian cells (33), AGO3/2 and (most) miRNA/siRNA
levels are positively correlated in C. reinhardtii (19, 21), suggesting
that AGO3/2 proteins are stabilized by association with sRNAs
and vice versa. As a further indication that FLAG-AGO3 proteins
were not exceedingly overexpressed, we also verified that the
transgenic strains had similar levels of endogenous miRNAs and
equivalent to those in the wild-type strain (SI Appendix, Fig. S8C).
RIP from the selected strains and subsequent reverse-transcriptase
(RT) PCR analysis revealed that FLAG-AGO3 binding to its target
mRNAs was not appreciably defective in the vig1 mutant (Fig. 5C).
Hence, the association of AGO3-(mi)RISC with target RNAs is
largely independent of VIG1.
Discussion
The biogenesis and function of sRNAs have been the subject of
extensive research in diverse eukaryotes. There is now good
evidence that, besides triggering mRNA degradation (in a slicer-
dependent or -independent manner), the (mi)RISC can also
cause translation repression of polyribosomal transcripts, in
some cases without or with minimal mRNA destabilization, in
animals, plants, and some protists like the alga C. reinhardtii (2,
4, 6, 11, 13). However, the actual mechanism(s) of this trans-
lation inhibition remains poorly characterized. As already men-
tioned, in metazoans, GW182/TNRC6 proteins are not required
for this type of silencing and, in land plants, the factors impli-
cated in translation repression do not provide clear insight into
the molecular mechanism(s).
In mammalian cells, some CDS miRNA target sites comprise
a new category of recognition elements, involving weak interac-
tions with the miRNA seed (nucleotides 2 to 7) but extensive
pairing with its 3′ half (11). The translationally repressed target
transcripts containing these elements remain associated with
translating ribosomes, without alteration in the overall ribosome
occupancy (11). In C. elegans, lin-41 mRNA also remains asso-
ciated with ribosomes, without alterations in ribosome occu-
pancy, despite strong translation repression by the let-7 miRNA
in L4 larvae (13). Moreover, ribosomal profiles from repressed
lin-41 transcripts showed no evidence for either premature ri-
bosomal dropoff or site-specific ribosome stalling as a possible
mechanism of let-7–triggered silencing (13). In D. melanogaster
S2 cells, an miRISC induced by serum starvation and causing
enhanced translation repression associates with mRNAs assem-
bled into polyribosomes (10). In A. thaliana, mRNAs targeted
for miRNA-mediated translation inhibition are also associated
with polyribosomes and the repression appears to occur in the
ER (2, 4, 15). However, no ribosome pausing upstream of CDS
miRNA-binding sites was observed in Ribo-seq or RNA degra-
dome analyses (14, 18). In Chlamydomonas, we reported that
transcripts translationally repressed by sRNAs also remain as-
sociated with polyribosomes without discernable changes in ri-
bosome occupancy (6), and global ribosome profiling did not
detect ribosome footprints piling up upstream of CDS miRNA
binding sites (20). These observations suggest the existence of a
similar mechanism of translation inhibition in widely divergent
eukaryotes but how the (mi)RISC triggers repression in a poly-
ribosomal context is not understood.
VIG/SERBP1 is an evolutionarily conserved eukaryotic pro-
tein (SI Appendix, Fig. S2). It was identified more than a decade
ago as a component of the (mi)RISC in D. melanogaster, C.
elegans, and human cells (24, 25) but its actual mechanistic
role(s) has not been elucidated. In C. elegans, VIG1 is required
for let-7–mediated repression of a lacZ-lin-41 reporter, but not
for (cleavage-mediated) RNAi (24). Since the endogenous lin-41
transcript is translationally repressed by let-7 while associated
with polyribosomes (13), it seems plausible that VIG1 is involved
in this process. However, C. elegans vig1 mutants also show re-
duced levels of mature let-7 miRNAs, suggesting alternative (not
mutually exclusive) VIG1 functions in miRISC loading and/or
miRNA stability (25). Nonetheless, a growing body of evidence
also supports the association of VIG/SERBP1 homologs with
ribosomes. S. cerevisiae Stm1, D. melanogaster VIG2, and mam-
malian SERBP1 interact with inactive ribosomes as clamping
factors that presumably prevent ribosome disassembly and decay
when translation is inhibited by nutrient starvation/stress condi-
tions (26–30). In addition, S. cerevisiae Stm1 and mammalian
SERBP1 have been shown to associate with translating polyri-
bosomes (30, 34, 35). Yeast Stm1 has been reported to perturb
the association of elongation factor eEF3 with ribosomes and
affect optimal translation elongation (34). Translation experi-
ments using yeast extracts also suggested that Stm1 represses
translation elongation, after formation of 80S ribosomes (30, 36).
Additionally, yeast Stm1 has been genetically linked to mRNA
decapping and degradation (30, 36). Mammalian SERBP1 has
been implicated in multiple functions but recent findings indicate
that most cytoplasmic SERBP1 is precipitated by ultracentrifu-
gation and associates with translating ribosomes (as a sub-
stoichiometric component of the 40S subunit) (35). One of the A.
thaliana VIG/SERBP1 homologs, AtRGGA, localizes in the cy-
toplasm and the perinuclear region (consistent with an associa-
tion with ribosomes, although this has not been examined) and is
involved in plant responses to osmotic stress (37).
The association of VIG/SERBP1 homologs with translating
ribosomes may be mediated, at least partly, by RACK1 (receptor
of activated protein C kinase 1), which is a component of the 40S
ribosomal subunit and also acts as a scaffold for many proteins
involved in diverse signaling pathways (38, 39). In yeast 2-hybrid
assays, mammalian SERBP1 interacts with RACK1 (40) and
proximity-dependent biotin identification analyses suggest that S.
cerevisiae Stm1 is deposited close to RACK1, within the 40S ri-
bosomal head region, when mRNAs are actively translated (29).
Interestingly, RACK1 has also been found to affect different as-
pects of the miRNA pathway, from biogenesis to effector functions,
in plants and metazoans (38, 39, 41). In C. elegans and human
cells, RACK1 copurifies with AGOs and has been proposed to
facilitate the recruitment of the miRISC to the ribosome (41).
RACK1 was also found in complexes with AGO1 in A. thaliana,
although its potential role in an sRNA effector complex has not
been examined (42).
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Like some of its homologs, Chlamydomonas VIG1 localizes
predominantly in the cytosol, with some preference for peri-
nuclear regions (Fig. 4 and SI Appendix, Fig. S7), and comigrates
with monoribosomes and polyribosomes by sucrose density gra-
dient sedimentation (Fig. 5A). Affinity purification of FLAG-
CBP-VIG1, from RNase A-treated cell lysates, indicated that
the association of VIG1 with components of the translation
machinery, including several translation initiation factors and
ribosomal proteins, is RNA-independent (Fig. 3A). Moreover,
the vig1-deleted mutant is hypersensitive to exposure to the
translation elongation inhibitor cycloheximide (SI Appendix, Fig.
S9B), suggesting that VIG1 may have some role(s) in ribosome
function/structure. Chlamydomonas VIG1 also copurifies with
AGO3 and DCL3 (Fig. 3A), consistent with it being a compo-
nent of the (mi)RISC, and its depletion prevented the sRNA-
mediated translation repression of polyribosomal transcripts
(Figs. 1 and 2). However, this protein was dispensable for
cleavage-mediated RNAi (SI Appendix, Fig. S4A) as well as for
the association of the AGO3 effector with polyribosomes and
with target transcripts (Fig. 5 B and C). Intriguingly, we have
previously reported that ribosomes associated with sRNA-
repressed transcripts showed reduced sensitivity to translation
inhibition by cycloheximide and suggested that sRNA-mediated
repression of protein synthesis in C. reinhardtii may involve al-
terations to the function/structural conformation of translating
ribosomes (6). Together with current results, it is tempting to
speculate that VIG1 is an ancillary ribosomal component and
plays a direct role in the translation repression of siRNA/miRNA-
targeted transcripts.
We hypothesize that the core (mi)RISC may interact (directly
or indirectly) with Chlamydomonas VIG1 to trigger translation
inhibition. Yet, VIG1 is predicted to be an intrinsically disor-
dered protein (SI Appendix, Fig. S1B). This type of protein does
not assume a single folded structure but instead rapidly inter-
converts between heterogeneous conformational states depending
on environmental conditions and/or partner interactions (43, 44).
Recent studies established that phase separation and protein–pro-
tein (and/or protein–RNA) interactions of a number of intrinsically
disordered proteins are also regulated by posttranslational modifi-
cations, in particular arginine methylation and serine/threonine/
tyrosine phosphorylation (43, 44). Indeed, the RG/RGG motifs
(45) of VIG1, which are extensively methylated in arginine resi-
dues in mammalian SERBP1 (46), may conceivably be required
for proper interaction with the core (mi)RISC and/or the actual
translation repression. In S. cerevisiae, which has lost all core
components of the RNAi machinery (47), the VIG1 homolog,
Stm1, lacks RG/RGG repeats (SI Appendix, Fig. S1A), consistent
with these motifs being related to an sRNA-associated function(s).
We propose a model of sRNA-mediated translation repres-
sion of polyribosomal transcripts whereby VIG1 is generally as-
sociated with ribosomes (SI Appendix, Fig. S11A) and may play a
minor (nonessential) role(s) in modulating ribosome function/
structure under normal growth conditions. In S. cerevisiae, Stm1
seems to influence the association of elongation factor eEF3 with
ribosomes, a protein that both stimulates eEF1A-dependent
binding of a cognate aminoacyl-tRNA to the ribosomal A site
and facilitates the release of deacylated tRNA from the ribo-
somal E site (34, 48). Although eEF3 was initially thought to be a
fungal-specific translation factor, eEF3-like (eEF3L) proteins
have now been identified in a wider range of eukaryotes (49).
Chlamydomonas encodes 2 eEF3L homologs, containing the
conserved domains involved in the interactions of yeast eEF3
with eEF1A and with the ribosome near the E site (48, 49).
Given the vig1 mutant hypersensitivity to cycloheximide, VIG1
may possibly modulate translation elongation (e.g., by influenc-
ing the activity/interactions of eEF3L factors) and/or the acces-
sibility of cycloheximide to its site of action at the ribosomal E
site (32). Alternatively, VIG1 may associate with translating ribo-
somes mainly in “standby mode,” until it is required for clamping
ribosomal subunits under nutrient starvation (29). Upon core (mi)
RISC binding to a target transcript in a polyribosomal context, we
hypothesize that it interacts (directly or indirectly) with VIG1 and
switches this protein into an alternative conformational state
leading to translation repression at potentially multiple steps (SI
Appendix, Fig. S11B). Since VIG1 copurifies with eIF3 subunits,
which are known to associate with the 40S ribosomal subunit (29,
50), it could conceivably affect the recruitment/interaction of
components of the translation initiation machinery. Additionally,
VIG1 associated with translating 80S ribosomes could inhibit
translation elongation, as reported for yeast Stm1 (30, 36). How-
ever, in an in vitro assay with rabbit reticulocyte lysates, mam-
malian SERBP1 was able to bind to multiple ribosomal complexes
but did not interfere with translation initiation or elongation (51),
possibly reflecting the proposed need of an interaction with the
core (mi)RISC for (nonfungal) VIG1 homologs to trigger translation
repression.
We favor the above model, characterized by an overall re-
duction (slowdown) of both translation initiation and elongation
rates, because, in Chlamydomonas, ribosomes remain associated
with sRNA-repressed transcripts, without noticeable changes in
ribosome occupancy, and appear to be actively translating al-
though with reduced sensitivity to inhibition by cycloheximide (6).
Intriguingly, pretreatment of the mammalian ECV-304 cell line
with cycloheximide also partly relieved the miRNA-mediated re-
pression of a Renilla luciferase reporter (52). Yet, alternative
models are also consistent with our observations. For instance,
mRNA-bound ribosomes could be simultaneously frozen on the
transcript, conceivably through liquid–liquid phase separation
triggered by conformational changes in intrinsically disordered
VIG1 interacting with the core (mi)RISC. Thus, the exact mech-
anism by which VIG1 may contribute to translation repression will
require further investigation.
Materials and Methods
Culture Conditions, Transgenic Strains, and Mutants. Unless noted otherwise,
C. reinhardtii cells were grown photoheterotrophically in Tris-acetate-
phosphate medium or photoautotrophically in minimal high-salt (HS) me-
dium (53, 54). For phenotypic analyses, cells grown to logarithmic phase in
TAP or HS media were serially diluted, spotted on plates of the appropriate
media (see figure legends), and incubated for 7 to 15 d under dim lights (6,
23, 54). Mutants and transgenic strains are described in SI Appendix, Ma-
terials and Methods.
RNA Analyses. Total cell RNA was purified with TRI Reagent (Molecular Re-
search Center), following the manufacturer’s instructions. For Northern blot
analyses of mRNAs, the isolated RNA was separated by agarose/formalde-
hyde gel electrophoresis, blotted onto nylon membranes, and hybridized
with 32P-labeled probes (6, 21, 55). For small RNA analyses, total RNA sam-
ples were resolved on 15% polyacrylamide/7 M urea gels and electroblotted
to Hybond-XL membranes (GE Healthcare) (6, 21, 55). Blots were hybridized
with 32P-labeled DNA probes at 40 °C for 48 h using the High Efficiency
Hybridization System (Molecular Research Center). Specific miRNAs were
detected by hybridization with complementary DNA oligonucleotides la-
beled at their 5′ termini with γ-[32P]ATP and T4 polynucleotide kinase (6, 21).
RNA-seq and Ribo-seq data for wild-type C. reinhardtii were reanalyzed
from Chung et al. (56) (accession nos. ERX558436 and ERX558438).
Immunoblot Analyses. Approximately 5 × 106 cells, grown to logarithmic
phase, were pelleted by centrifugation and resuspended in 50 μL of SDS gel-
running buffer. Ten-microliter aliquots of boiled samples were separated by
SDS/PAGE and electrophoretically transferred to nitrocellulose membranes
(54, 55). Tryptophan synthase β-subunit was immunodetected by overnight
incubation at 4 °C with a 1:5,000 dilution of a rabbit antibody raised against
the Camptotheca acuminata enzyme (a generous gift from Thomas
McKnight, Texas A&M University, College Station, Texas) (6, 21). AGO3 was
detected by incubation with a 1:10,000 dilution of a rabbit antibody raised
against a C-terminal peptide (ASRSGRGAGAAEGG) conjugated to keyhole
limpet hemocyanin (KLH) (21). This antibody also cross-reacts with Chlamy-
domonas AGO2 (19), but the steady-state level of this protein is, at least,
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1 order of magnitude lower than that of AGO3 [PaxDb (57)]. The
Cre16.g683650 protein was immunodetected by overnight incubation at 4 °C
with a 1:10,000 dilution of a rabbit antibody raised against a C-terminal
peptide (GIKPSAHKRGGVRM) conjugated to KLH (22). Commercially avail-
able antibodies were used to detect histone H3 (Abcam; ab1791), RPL37
(Agrisera; AS12 2115), COX2B (Agrisera; AS06 151), RPS14 (Agrisera; AS12
2111), RBCS1/2 (Agrisera; AS07 259), and the AcV5 epitope tag (antibaculovirus
envelope gp64 protein; eBioscience; 14-6995), which was engineered as part of
the FLAG-CBP tag.
Affinity Purification of FLAG-CBP–Tagged VIG1 and Protein Identification by
Mass Spectrometry. To purify VIG1-associated polypeptides, a complemented
vig1 transgenic strain [vig1(tagVIG1)-3] was grown to midlogarithmic phase
in TAP medium (containing 7 μM 5-FI) and cells were collected by centrifu-
gation. For each experiment, ∼2 × 1010 cells were resuspended in lysis buffer
(20 mM Tris·HCl, pH 7.5, 150 mM NaCl, 2 mM Mg[CH3COO]2·4H2O, 2.5 mM
CaCl2, 1 mM imidazole, 10 mM β-mercaptoethanol, and 10% glycerol) sup-
plemented with 2.0 mM benzamidine, 0.2 mM phenylmethanesulfonyl
fluoride (PMSF), 5 μL/mL plant protease inhibitor mixture (Sigma), and 30 μg/mL
RNase A. Cells were broken by 2 passages through a French press at 5,000 psi
and the lysate was clarified by centrifugation at 16,000 × g for 30 min at 4 °C.
The extract was then incubated with buffer-equilibrated calmodulin-
Sepharose beads (GE Healthcare) for 16 h at 4 °C. Subsequent purification
steps were performed as previously described (58). FLAG-CBP-Ble purification,
following the same protocol, was used as a negative control. Isolated proteins
were fractionated by 10% SDS/PAGE, stained with Sypro Ruby (Bio-Rad),
digested in-gel with trypsin, and identified by tandem mass spectrometry as
described (58). We observed that VIG1 migrates anomalously on SDS/PAGE and
appears larger than its predicted size, as previously reported for mammalian
SERBP1 (35).
In Vitro RISC Activity. To test for sequence-specific cleavage activity, VIG1 and
associated proteins were purified as described above. After the final regular
wash, the beads were rewashed and resuspended with RISC activity buffer
(30 mM Hepes, pH 7.5, 100 mM NaCl, 5 mM Mg[CH3COO]2, 2 mM CaCl2, and
0.5 mM DTT). The in vitro reactions contained 17 μL resuspended beads in
RISC activity buffer, 1 μL γ-32P–labeled synthetic MAA7 RNA (1 pmol/μL 5′-
GACCAGCACUGUGCUUUGACAGACAAGCUCACGCG-3′; IDT), 1 μL 40 U/μL
RNasin Plus (Promega), and 1 μL of a mixture of 0.2 mM GTP and 1 mM ATP
(final volume 20 μL). For EDTA treatments, the reactions were supplemented
with 8 mM EDTA. A nonhomologous, 32P-labeled RNA (5′-GUGGAUU-
GAUCCCAGCCAGGCGAAA-3′; IDT) was also used as a negative-control sub-
strate. All reactions were allowed to proceed at room temperature for 0, 20,
or 40 min. At each time point, an aliquot was transferred to a new tube on
ice and an equal volume of formamide loading buffer (55) was added.
Stopped reactions were heated at 65 °C for 3 min, quickly cooled on ice, and
3 μL was then resolved on 15% denaturing polyacrylamide gels and detected
by autoradiography.
Immunofluorescence Microscopy. Immunofluorescence microscopy of
Chlamydomonas was performed with minor modifications to published
protocols (59, 60). After allowing cells to adhere to polyethyleneimine-
coated slides (Sigma), they were fixed using 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 30 min. Slides were then washed twice
in −20 °C methanol for 10 min each. After rehydration in PBS, cells were
further permeabilized with 0.5% Triton X-100 and rewashed in PBS. Fixed
cells were then incubated in blocking buffer (10 mM K2HPO4/KH2PO4, pH
7.2, 5% glycerol, 1% BSA, 5% normal goat serum, 1% cold-water fish
gelatin, and 0.04% sodium azide) for 2 h. After blocking, cells were in-
cubated with 1:10,000 diluted primary anti-AcV5 antibody at 4 °C for 24 h.
The secondary antibody, goat anti-mouse IgG conjugated to Alexa Fluor
488 (Invitrogen; A11001), was diluted 1:500 in blocking buffer and in-
cubated with the cells for 2 h at room temperature. Following exposure to
the secondary antibody, samples were stained with 5 μM DAPI, washed in
PBS, and finally mounted with Gel Mount (Sigma). Cells were imaged using
an Olympus FluoView 500 confocal laser-scanning microscope.
Polyribosome Profile Analyses. These experiments were carried out as pre-
viously described (6) and are briefly outlined in SI Appendix, Materials
and Methods.
RNA-Binding Protein Immunoprecipitation. C. reinhardtii strains, expressing
FLAG-AGO3 or FLAG-Ble, were grown to midlogarithmic phase in TAP me-
dium, and ∼4 × 109 cells were pelleted by centrifugation and resuspended in
10 mL of lysis buffer (50 mM Tris·HCl, pH 7.5, 120 mM NaCl, 2 mM benza-
midine, 0.2 mM PMSF, and 10% glycerol) containing 5 μL/mL plant protease
inhibitor mixture (Sigma). From this step on, cells and lysates were always
kept on ice. Cells were broken by 2 passages through a French press at a
pressure of ∼2,000 psi. Cell lysates were then centrifuged at 16,000 × g for
30 min. CHAPS (0.1% final concentration) was added to the supernatant and
an aliquot (∼10%) was saved for input control analyses of proteins and
RNAs. The remaining supernatant was incubated with buffer-equilibrated
anti–FLAG-M2 agarose beads (Sigma) for 2 h, and then the beads were
washed 5 times with lysis buffer containing 0.1% CHAPS and 5 μL/mL plant
protease inhibitor mixture. Proteins/RNAs associated with the beads were
eluted by incubation with lysis buffer (without glycerol) containing 150 μg/mL
3×FLAG peptide (Sigma). RNA was purified from the eluate, precipitated with
glycogen as carrier, and used for RT-PCR analyses (55).
Reverse-Transcriptase PCR Analyses. First-strand cDNA synthesis and PCR re-
actions were performed as previously described (21, 54, 55). Specific details
and primers are described in SI Appendix, Materials and Methods.
Data Availability. All data and protocols used to support the findings of this
study have been included in the manuscript and SI Appendix or made
available through the National Center for Biotechnology Information.
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